Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by pennyDoctoron Aug 01, 2013 11:24pm

214 Views

Post# 21645602

Cats out of the bag

https://www.linkedin.com/profile/view?id=26389906&authType=name&authToken=a5xw&trk=miniprofile-primary-view-button&_mSplash=1

Stock so far undervalued.

Find in the linked in site connections to
Roche, Takeda Pharmaceuticals, Johnson&Johnson (Belgium Janssen)

only reason for Neil to have communities with these companies is ....... $$$$$$$$

Bullboard Posts

A Look into the Future of Chronic Pain Management